Use of Machine Learning to Compare Disease Risk Scores and Propensity Scores Across Complex Confounding Scenarios: A Simulation Study.

Journal: Pharmacoepidemiology and drug safety
Published Date:

Abstract

PURPOSE: The surge of treatments for COVID-19 in the second quarter of 2020 had a low prevalence of treatment and high outcome risk. Motivated by that, we conducted a simulation study comparing disease risk scores (DRS) and propensity scores (PS) using a range of scenarios with different treatment prevalences and outcome risks.

Authors

  • Yuchen Guo
    Institute for Brain and Cognitive Sciences, Tsinghua University, Beijing, China.
  • Victoria Y Strauss
    Boehringer Ingelheim, Binger Str. 173, 55218, Ingelheim am Rhein, Germany.
  • Sara Khalid
    Center for Statistics in Medicine, Botnar Research Center, University of Oxford, Oxford, UK. Electronic address: sara.khalid@ndorms.ox.ac.uk.
  • Daniel Prieto-Alhambra
    Pharmaco- and Device Epidemiology, Centre for Statistics in Medicine, NDORMS, University of Oxford, Oxford, UK.